Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

Leucht S, Wahlbeck K, Hamann J, Kissling W.

Lancet. 2003 May 10;361(9369):1581-9. Review.

PMID:
12747876
2.

Risperidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Review.

3.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
4.

Olanzapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2. Review.

5.

Clozapine versus other atypical antipsychotics for schizophrenia.

Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006633. doi: 10.1002/14651858.CD006633.pub2. Review.

6.

Ziprasidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Bhoopathi PS, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2. Review.

7.

New generation antipsychotics for first episode schizophrenia.

Rummel C, Hamann J, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2003;(4):CD004410. Review.

PMID:
14584012
8.

Amisulpride versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Silveira da Mota Neto JI, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006624. doi: 10.1002/14651858.CD006624.pub2. Review.

9.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, Srisurapanont M, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. doi: 10.1002/14651858.CD006625.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD006625.

10.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM.

Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27. Review. Erratum in: Lancet. 2013 Sep 14;382(9896):940.

PMID:
23810019
11.

Amisulpride for schizophrenia.

Mota NE, Lima MS, Soares BG.

Cochrane Database Syst Rev. 2002;(2):CD001357. Review.

PMID:
12076408
12.

Zotepine versus other atypical antipsychotics for schizophrenia.

Subramanian S, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Kissling W, Leucht S, Komossa K.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006628. doi: 10.1002/14651858.CD006628.pub3. Review.

13.

Sertindole versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Schmidt F, Lewis R, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006752. doi: 10.1002/14651858.CD006752.pub2. Review.

14.

Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.

Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Kissling W, Davis JM, Leucht S.

Schizophr Bull. 2012 Jan;38(1):167-77. doi: 10.1093/schbul/sbq042. Epub 2010 May 31. Review.

15.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
16.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
17.

Aripiprazole versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006569. doi: 10.1002/14651858.CD006569.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006569.

18.

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.

Gao K, Kemp DE, Ganocy SJ, Gajwani P, Xia G, Calabrese JR.

J Clin Psychopharmacol. 2008 Apr;28(2):203-9. doi: 10.1097/JCP.0b013e318166c4d5. Review.

19.

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.

Haddad PM, Das A, Keyhani S, Chaudhry IB.

J Psychopharmacol. 2012 May;26(5 Suppl):15-26. doi: 10.1177/0269881111424929. Epub 2011 Nov 5. Review.

PMID:
22057019
20.

Effects of newer antipsychotics on extrapyramidal function.

Tarsy D, Baldessarini RJ, Tarazi FI.

CNS Drugs. 2002;16(1):23-45. Review. Erratum in: CNS Drugs. 2003;17(3):202.

PMID:
11772117
Items per page

Supplemental Content

Write to the Help Desk